Safety and Efficacy of MILEP Versus Standard EEP
Recruiting
N/A
Interventional Study
Benign Prostate Hypertrophy(BPH)
LUTS(Lower Urinary Tract Symptoms)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 340 (estimated)
- Sponsor
- Sechenov University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures.
Objective: to compare the efficacy and safety of MiLEP and standard EEP with a thulium fiber …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
LUTS presence, proven by:
1. IPSS questionnaire (Score \>20);
2. OR uroflowmetry result (Qmax \<10 ml/s);
Exclusion Criteria:
* Prostate volume \> 120 cc
* Prostate cancer on pathology;
* Urethral strictures;
* Bladder calculi;
* Prior prostate surgery;
* Neurogenic bladder d…
Contacts